1. Home
  2. ESLA vs VSME Comparison

ESLA vs VSME Comparison

Compare ESLA & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESLA
  • VSME
  • Stock Information
  • Founded
  • ESLA 2021
  • VSME 2013
  • Country
  • ESLA United States
  • VSME Hong Kong
  • Employees
  • ESLA N/A
  • VSME N/A
  • Industry
  • ESLA Biotechnology: Biological Products (No Diagnostic Substances)
  • VSME
  • Sector
  • ESLA Health Care
  • VSME
  • Exchange
  • ESLA Nasdaq
  • VSME Nasdaq
  • Market Cap
  • ESLA 48.9M
  • VSME 56.9M
  • IPO Year
  • ESLA N/A
  • VSME 2023
  • Fundamental
  • Price
  • ESLA $2.92
  • VSME $0.30
  • Analyst Decision
  • ESLA Strong Buy
  • VSME
  • Analyst Count
  • ESLA 1
  • VSME 0
  • Target Price
  • ESLA $16.00
  • VSME N/A
  • AVG Volume (30 Days)
  • ESLA 492.9K
  • VSME 737.6K
  • Earning Date
  • ESLA 11-13-2025
  • VSME 12-21-2025
  • Dividend Yield
  • ESLA N/A
  • VSME N/A
  • EPS Growth
  • ESLA N/A
  • VSME N/A
  • EPS
  • ESLA N/A
  • VSME N/A
  • Revenue
  • ESLA N/A
  • VSME $7,483,152.00
  • Revenue This Year
  • ESLA N/A
  • VSME N/A
  • Revenue Next Year
  • ESLA N/A
  • VSME N/A
  • P/E Ratio
  • ESLA N/A
  • VSME N/A
  • Revenue Growth
  • ESLA N/A
  • VSME N/A
  • 52 Week Low
  • ESLA $0.70
  • VSME $0.29
  • 52 Week High
  • ESLA $3.15
  • VSME $3.21
  • Technical
  • Relative Strength Index (RSI)
  • ESLA 65.89
  • VSME 18.25
  • Support Level
  • ESLA $2.20
  • VSME $0.29
  • Resistance Level
  • ESLA $3.15
  • VSME $1.67
  • Average True Range (ATR)
  • ESLA 0.43
  • VSME 0.20
  • MACD
  • ESLA 0.03
  • VSME -0.08
  • Stochastic Oscillator
  • ESLA 83.21
  • VSME 2.31

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

Share on Social Networks: